• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

巴西队列中三阴性和非三阴性乳腺癌的生存研究

Survival Study of Triple-Negative and Non-Triple-Negative Breast Cancer in a Brazilian Cohort.

作者信息

Gonçalves Homero, Guerra Maximiliano Ribeiro, Duarte Cintra Jane Rocha, Fayer Vívian Assis, Brum Igor Vilela, Bustamante Teixeira Maria Teresa

机构信息

Instituto Oncológico de Juiz de Fora/Hospital 9 de Julho, Juiz de Fora, Brazil.

Post-Graduate Program in Health, Faculty of Medicine, Universidade Federal de Juiz de Fora (UFJF), Juiz de Fora, Brazil.

出版信息

Clin Med Insights Oncol. 2018 Jul 27;12:1179554918790563. doi: 10.1177/1179554918790563. eCollection 2018.

DOI:10.1177/1179554918790563
PMID:30083066
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6071162/
Abstract

OBJECTIVE

To analyze the clinical, pathological, and sociodemographic aspects between triple-negative breast cancer (TNBC) and non-TNBC in a Brazilian cohort and identify potential prognostic factors.

METHODS

This hospital-based retrospective cohort study included 447 women with breast cancer treated at referral centers in Southeastern Brazil. Overall and disease-free survival were compared; prognostic factors were evaluated.

RESULTS

Triple-negative breast cancer corresponded to 19.5% of breast cancer diagnosis and was more prevalent among nonwhite and less educated women. The patients with TNBC tended to present with stage III cancer, high p53 expression, lymphocytic infiltration, and multifocality and treated with radical surgery and chemotherapy. The 5-year overall and disease-free survival were 62.1% and 57.5% for TNBC and 80.8% and 75.3% for non-TNBC, respectively ( < .001). The TNBC recurrence was associated with multicentricity, whereas lymph node involvement increased the risk of both recurrence and death. Non-TNBC worse clinical course was associated with nonwhite ethnicity, lower education level, lymph node involvement, and advanced stage.

CONCLUSIONS

Triple-negative breast cancer exhibited a more aggressive behavior, earlier and more frequent recurrence, and worse survival compared with non-TNBC. While biological and social variables were associated with poorer prognosis in non-TNBC, only lymph node involvement and multicentricity were correlated with worse clinical outcomes in TNBC.

摘要

目的

分析巴西队列中三阴性乳腺癌(TNBC)与非三阴性乳腺癌在临床、病理及社会人口学方面的特征,并确定潜在的预后因素。

方法

这项基于医院的回顾性队列研究纳入了447例在巴西东南部转诊中心接受治疗的乳腺癌女性患者。比较总生存率和无病生存率;评估预后因素。

结果

三阴性乳腺癌占乳腺癌诊断病例的19.5%,在非白人和受教育程度较低的女性中更为普遍。TNBC患者倾向于表现为III期癌症、p53高表达、淋巴细胞浸润和多灶性,并接受根治性手术和化疗。TNBC的5年总生存率和无病生存率分别为62.1%和57.5%,非TNBC分别为80.8%和75.3%(P<0.001)。TNBC复发与多中心性相关,而淋巴结受累增加了复发和死亡风险。非TNBC较差的临床病程与非白人种族、较低教育水平、淋巴结受累和晚期有关。

结论

与非TNBC相比,三阴性乳腺癌表现出更具侵袭性的行为、更早且更频繁的复发以及更差的生存率。虽然生物学和社会变量与非TNBC较差的预后相关,但在TNBC中只有淋巴结受累和多中心性与较差的临床结局相关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/73c4/6071162/bf6da2c66df8/10.1177_1179554918790563-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/73c4/6071162/bf6da2c66df8/10.1177_1179554918790563-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/73c4/6071162/bf6da2c66df8/10.1177_1179554918790563-fig1.jpg

相似文献

1
Survival Study of Triple-Negative and Non-Triple-Negative Breast Cancer in a Brazilian Cohort.巴西队列中三阴性和非三阴性乳腺癌的生存研究
Clin Med Insights Oncol. 2018 Jul 27;12:1179554918790563. doi: 10.1177/1179554918790563. eCollection 2018.
2
Comparison of Clinicopathological Features and Prognosis in Triple-Negative and Non-Triple Negative Breast Cancer.三阴性乳腺癌与非三阴性乳腺癌的临床病理特征及预后比较
J Cancer. 2016 Jan 1;7(2):167-73. doi: 10.7150/jca.10944. eCollection 2016.
3
Beyond Axillary Lymph Node Metastasis, BMI and Menopausal Status Are Prognostic Determinants for Triple-Negative Breast Cancer Treated by Neoadjuvant Chemotherapy.除腋窝淋巴结转移外,体重指数和绝经状态是新辅助化疗治疗三阴性乳腺癌的预后决定因素。
PLoS One. 2015 Dec 18;10(12):e0144359. doi: 10.1371/journal.pone.0144359. eCollection 2015.
4
Association between systemic immune-inflammation index and neoadjuvant chemotherapy efficacy as well as prognosis in triple-negative breast cancer.全身免疫炎症指数与三阴性乳腺癌新辅助化疗疗效及预后的关系。
Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2021;46(9):958-965. doi: 10.11817/j.issn.1672-7347.2021.200951.
5
Metaplastic Carcinoma of the Breast Is More Aggressive Than Triple-negative Breast Cancer: A Study From a Single Institution and Review of Literature.乳腺化生性癌比三阴性乳腺癌更具侵袭性:单中心研究及文献复习。
Clin Breast Cancer. 2017 Aug;17(5):382-391. doi: 10.1016/j.clbc.2017.04.009. Epub 2017 Apr 26.
6
Clinical characteristics and prognostic analysis of triple-negative breast cancer patients.三阴性乳腺癌患者的临床特征及预后分析
Mol Clin Oncol. 2014 Mar;2(2):245-251. doi: 10.3892/mco.2013.230. Epub 2013 Dec 20.
7
[Comparison of biological behavior between triple-negative breast cancer and non-triple- negative breast cancer].三阴性乳腺癌与非三阴性乳腺癌生物学行为的比较
Nan Fang Yi Ke Da Xue Xue Bao. 2011 Oct;31(10):1729-32.
8
The Outcome of Patients with Triple Negative Breast Cancer: The Turkish Oncology Group Experience.三阴性乳腺癌患者的治疗结果:土耳其肿瘤学组的经验
J Breast Health. 2014 Oct 1;10(4):209-215. doi: 10.5152/tjbh.2014.1904. eCollection 2014 Oct.
9
The role of BRCA1-IRIS in the development and progression of triple negative breast cancers in Egypt: possible link to disease early lesion.BRCA1-IRIS在埃及三阴性乳腺癌发生发展中的作用:与疾病早期病变的可能联系
BMC Cancer. 2017 May 12;17(1):329. doi: 10.1186/s12885-017-3283-8.
10
Clinicopathological features of triple-negative breast cancer in Taiwanese women.台湾地区女性三阴性乳腺癌的临床病理特征。
Int J Clin Oncol. 2011 Oct;16(5):500-5. doi: 10.1007/s10147-011-0211-9. Epub 2011 Apr 1.

引用本文的文献

1
Androgen receptor expression in triple negative breast cancer: an Algerian population study.三阴性乳腺癌中雄激素受体的表达:一项阿尔及利亚人群研究。
Libyan J Med. 2025 Dec;20(1):2535778. doi: 10.1080/19932820.2025.2535778. Epub 2025 Jul 20.
2
The inner nuclear membrane protein, Banf1, has an essential role in triple negative breast cancer cell proliferation and survival.内核膜蛋白Banf1在三阴性乳腺癌细胞的增殖和存活中起着至关重要的作用。
Sci Rep. 2025 Jul 15;15(1):25492. doi: 10.1038/s41598-025-10346-x.
3
Excavatolide C has oxidative-stress-dependent antiproliferative and apoptotic effects against breast cancer cells.

本文引用的文献

1
Tumour-infiltrating lymphocytes and prognosis in different subtypes of breast cancer: a pooled analysis of 3771 patients treated with neoadjuvant therapy.浸润淋巴细胞与不同亚型乳腺癌患者预后的关系:新辅助化疗治疗 3771 例患者的汇总分析
Lancet Oncol. 2018 Jan;19(1):40-50. doi: 10.1016/S1470-2045(17)30904-X. Epub 2017 Dec 7.
2
The Evolution of Triple-Negative Breast Cancer: From Biology to Novel Therapeutics.三阴性乳腺癌的演变:从生物学到新型疗法
Am Soc Clin Oncol Educ Book. 2016;35:34-42. doi: 10.1200/EDBK_159135.
3
Invasive Breast Cancer Version 1.2016, NCCN Clinical Practice Guidelines in Oncology.
掘扁柏内酯C对乳腺癌细胞具有氧化应激依赖性的抗增殖和凋亡作用。
BMC Cancer. 2025 Jul 1;25(1):1023. doi: 10.1186/s12885-025-14276-9.
4
Clinical, humanistic and economic burden associated with recurrence among patients with early-stage cancers: a systematic literature review.早期癌症患者复发相关的临床、人文和经济负担:一项系统文献综述
Front Oncol. 2025 May 26;15:1575813. doi: 10.3389/fonc.2025.1575813. eCollection 2025.
5
Effect of chemotherapy timing in triple-negative breast cancer: a real-world evidence study.三阴性乳腺癌化疗时机的影响:一项真实世界证据研究。
Breast Cancer Res Treat. 2025 May 21. doi: 10.1007/s10549-025-07716-4.
6
Unveiling the Landscape of PD-L1 Expression and Tumor-Infiltrating Lymphocyte Subtypes in Advanced Triple-Negative Breast Cancer in Brazil.揭示巴西晚期三阴性乳腺癌中PD-L1表达情况及肿瘤浸润淋巴细胞亚型
Breast Cancer (Dove Med Press). 2025 Apr 15;17:349-358. doi: 10.2147/BCTT.S499373. eCollection 2025.
7
Human Cytomegalovirus Infection and Breast Cancer: A Literature Review of Clinical and Experimental Data.人巨细胞病毒感染与乳腺癌:临床与实验数据的文献综述
Biology (Basel). 2025 Feb 8;14(2):174. doi: 10.3390/biology14020174.
8
A Narrative Review of the Clinical, Humanistic, and Economic Value of Pembrolizumab-Based Immunotherapy for the Treatment of Breast and Gynecologic Cancers.帕博利珠单抗免疫疗法治疗乳腺癌和妇科癌症的临床、人文及经济价值的叙述性综述
Oncol Ther. 2024 Dec;12(4):701-734. doi: 10.1007/s40487-024-00308-0. Epub 2024 Oct 25.
9
ANKRD1 Promotes Breast Cancer Metastasis by Activating NF-B-MAGE-A6 Pathway.锚蛋白重复结构域1通过激活核因子-κB-黑色素瘤抗原基因A6通路促进乳腺癌转移。
Cancers (Basel). 2024 Sep 27;16(19):3306. doi: 10.3390/cancers16193306.
10
On discovery of novel hub genes for ER+ and TN breast cancer types through RNA seq data analyses and classification models.通过 RNA 测序数据分析和分类模型发现 ER+ 和 TN 乳腺癌新型枢纽基因。
Sci Rep. 2024 Sep 6;14(1):20840. doi: 10.1038/s41598-024-69721-9.
浸润性乳腺癌,2016年第1版,美国国立综合癌症网络(NCCN)肿瘤学临床实践指南
J Natl Compr Canc Netw. 2016 Mar;14(3):324-54. doi: 10.6004/jnccn.2016.0037.
4
Comparison of Clinicopathological Features and Prognosis in Triple-Negative and Non-Triple Negative Breast Cancer.三阴性乳腺癌与非三阴性乳腺癌的临床病理特征及预后比较
J Cancer. 2016 Jan 1;7(2):167-73. doi: 10.7150/jca.10944. eCollection 2016.
5
Clinical validity of tumor-infiltrating lymphocytes analysis in patients with triple-negative breast cancer.三阴性乳腺癌患者肿瘤浸润淋巴细胞分析的临床有效性。
Ann Oncol. 2016 Feb;27(2):249-56. doi: 10.1093/annonc/mdv571. Epub 2015 Nov 23.
6
Triple negative breast cancer: looking for the missing link between biology and treatments.三阴性乳腺癌:探寻生物学与治疗之间缺失的环节
Oncotarget. 2015 Sep 29;6(29):26560-74. doi: 10.18632/oncotarget.5306.
7
Highlights from the 14(th) St Gallen International Breast Cancer Conference 2015 in Vienna: Dealing with classification, prognostication, and prediction refinement to personalize the treatment of patients with early breast cancer.2015年维也纳第14届圣加仑国际乳腺癌大会亮点:应对分类、预后评估及预测细化,实现早期乳腺癌患者治疗的个性化。
Ecancermedicalscience. 2015 Mar 31;9:518. doi: 10.3332/ecancer.2015.518. eCollection 2015.
8
Characteristics of Multifocal and Multicentric Breast Cancers.多灶性和多中心性乳腺癌的特征
Ann Surg Oncol. 2015 Aug;22(8):2475-82. doi: 10.1245/s10434-015-4430-6. Epub 2015 Mar 25.
9
Androgen receptor, EGFR, and BRCA1 as biomarkers in triple-negative breast cancer: a meta-analysis.雄激素受体、表皮生长因子受体及乳腺癌1号基因作为三阴性乳腺癌生物标志物的荟萃分析
Biomed Res Int. 2015;2015:357485. doi: 10.1155/2015/357485. Epub 2015 Jan 28.
10
"Clinical significance of multifocal and multicentric breast cancers and choice of surgical treatment: a retrospective study on a series of 1158 cases".多灶性和多中心性乳腺癌的临床意义及手术治疗选择:对1158例病例的回顾性研究
BMC Surg. 2015 Jan 14;15(1):1. doi: 10.1186/1471-2482-15-1.